Insiders · ALMR

Yuling Luo

Chief Executive Officer, Director at Alamar Biosciences, Inc. (ALMR)

Yuling Luo has filed 1 insider report with the SEC since April 2026, as chief Executive Officer and director at Alamar Biosciences, Inc. (ALMR). The latest filing, on April 21, 2026, reports grant or award, conversion of a derivative and other acquisition or disposition at Alamar Biosciences, Inc. (ALMR).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Yuling Luo is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Alamar Biosciences, Inc. logo
ALMR
Alamar Biosciences, Inc.
Chief Executive Officer, Director1,940,574$30.55Apr 21, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Other insiders at the same companies

Questions about Yuling Luo

What is Yuling Luo's role at Alamar Biosciences, Inc.?
Yuling Luo reports to the SEC as chief Executive Officer and director at Alamar Biosciences, Inc. (ALMR), according to the latest filing on April 21, 2026.
How many shares does Yuling Luo own?
After the latest filing that states it, Yuling Luo directly owned 1,940,574 shares of Alamar Biosciences, Inc. (ALMR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Yuling Luo bought or sold stock recently?
No open-market purchases or sales by Yuling Luo are on file. The filings report grant or award, conversion of a derivative and other acquisition or disposition.
How do I get alerts when Yuling Luo files?
Follow Yuling Luo on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Yuling Luo (SEC CIK 0002126941). Totals count each trade once, skipping amendments whose original is on file, from Apr 21, 2026 on. View on SEC EDGAR